Evaluating how significant carotid stenosis affects retinal blood flow using automated oximetry
Official title: Impact of Significant Carotid Stenosis on Retinal Perfusion Measured Via Automated Retinal Oximetry
Run by University Hospital Olomouc · NCT06085612 · Data updated 2026-11-12
This study is testing how narrowing of the carotid artery affects blood flow in the retina to see if more severe narrowing leads to less blood flow.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University Hospital Olomouc Academic / other |
| Locations | 1 site (Olomouc) |
| Status | Recruiting |
| Started | January 1, 2023 |
| Main results expected | January 1, 2027 |
| Study ends | January 1, 2028 |
| Registry record updated | October 23, 2023 |
| Trial ID | NCT06085612 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with significant carotid stenosis being examined at the University Hospital Olomouc, regardless of the reason for their examination.
✕Probably not a fit
Patients who are unable to undergo proper ophthalmological examinations, particularly those who cannot participate in automated retinal oximetry, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the impact of significant carotid stenosis on retinal perfusion through the use of automated retinal oximetry. By enrolling 50 patients annually, the study will analyze the relationship between the severity of carotid stenosis and changes in retinal blood flow. The hypothesis is that greater stenosis leads to reduced retinal perfusion, which may be indicated by higher arteriovenous saturation differences. This research could provide insights that expand the criteria for surgical revascularization in patients with carotid stenosis.
Why it matters
Potential benefit: If successful, this study could improve the evaluation and treatment options for patients with significant carotid stenosis, potentially reducing the risk of ischemic strokes.
How similar studies have gone: While the approach of using automated retinal oximetry in this context is relatively novel, similar studies have suggested potential benefits in understanding vascular health.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Study population will include patients examined in ultrasound laboratory in Neurology department of University Hospital Olomouc, regardless of incidental finding of stenosis, examination due to acute symptoms or regular checkup of known stenosis. Exclusion Criteria: * patients unable undergo ophthalmological examination properly, especially on automated retinal oximetry.
Where it's running
-
University Hospital Olomouc
Olomouc, Czechia Recruiting
Study contacts
- Study coordinator: Michal Král, MD., Ph.D.
- Email: michal.kral@fnol.cz
- Phone: +420604171594
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Paired VNS: How the Brain and Pupils Respond in Stroke Patients
This study tests real-time physiologic responses to paired VNS in adults with chronic motor impairment after ischemic stroke to help tailor dosing.
-
NeuroAiD test in mild to moderate ischemic stroke patients
This study tests whether adding MLC901 (NeuroAiD II) to standard stroke care helps adults who recently had an ischemic stroke recover better than standard care alone.
-
Using IMPROVE to guide carotid revascularisation decisions
This trial tests whether using the IMPROVE MRI-based score to select patients for carotid revascularisation is as good as standard care based mainly on stenosis degree, among people who have had a recent stroke or TIA due to carotid disease.
-
High-intensity interval versus moderate continuous exercise for stroke-related muscle loss
This will test whether high-intensity interval training (HIIT) or moderate-intensity continuous training (MCIT) better helps people 1–6 months after an ischemic stroke who have muscle loss regain muscle mass, strength, walking ability, and quality of life.
-
Test of adding a very low-dose edoxaban to standard antiplatelet therapy to prevent another stroke in adults 75 and older
This trial tests whether adding a tiny amount of edoxaban to aspirin or clopidogrel can better prevent a second stroke in people aged 75+ who recently had an ischemic stroke.
-
HR-MRI–Directed Tirofiban Therapy for Late-Window ICAS-LAA Stroke
We’re testing whether tirofiban plus dual antiplatelet therapy, guided by high-resolution MRI of the brain’s blood vessels, can help people with intracranial large-artery atherosclerosis strokes that begin more than 24 hours after onset.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.